Volume 19, Number 6—June 2013
CME ACTIVITY - Research
Foodborne Botulism in Canada, 1985–2005
Table 5
Specimen type | Test type | No. outbreaks | No. specimens | No. (%) specimens with positive results |
---|---|---|---|---|
Serum |
BoNT |
82 |
212 |
74 (34.9) |
Gastric contents | BoNT | 48 | 73 | 8 (11.0) |
Clostridium botulinum |
47 |
78 |
40 (51.3) |
|
Feces | BoNT | 57 | 84 | 29 (34.5) |
C. botulinum |
60 |
139 |
56 (40.3) |
|
Liver | ||||
Blood | BoNT | 1 | 2 | 0 (0.0) |
Tissue |
C. botulinum |
1 |
2 |
2 (100) |
Cerebrospinal fluid |
BoNT |
1 |
1 |
0 (0.0) |
Food | BoNT | 69 | 69 | 54 (78.3) |
C. botulinum | 66 | 66 | 55 (83.3) |
*BoNT, botulinum neurotoxin.
Page created: May 23, 2013
Page updated: May 23, 2013
Page reviewed: May 23, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.